Cite
HARVARD Citation
Kedor, C. et al. (n.d.). AB1037 CANAKINUMAB FOR TREATMENT OF ADULT ONSET STILL'S DISEASE-RESULTS OF THE 24 WEEKS TREATMENT AND BEYOND: A MULTI-CENTRE, PLACEBO-CONTROLLED STUDY (CONSIDER). Annals of the rheumatic diseases. pp. 1809-1810. [Online].